DA-9601 for erosive gastritis: Results of a double-blind placebo-controlled phase III clinical trial

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 16

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

346

HTML

3971

Figures (1-5)

153

Tables (1-5)

146

Sum=4616

Aug 15, 2004 (publication date) through May 5, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical Research

World J Gastroenterol. Aug 15, 2004; 10(16): 2379-2382
Published online Aug 15, 2004. doi: 10.3748/wjg.v10.i16.2379

Table 2 Evaluation of efficacy in individual symptom

Score	Criteria
1 (none)	No symptom
2 (weak)	Symptoms occurred once a week
3 (moderate)	The symptoms did not affect their life and occurred more than twice a week
4 (strong)	The symptoms affected their everyday life and occurred daily

Citation: Seol SY, Kim MH, Ryu JS, Choi MG, Shin DW, Ahn BO. DA-9601 for erosive gastritis: Results of a double-blind placebo-controlled phase III clinical trial. World J Gastroenterol 2004; 10(16): 2379-2382
URL: https://www.wjgnet.com/1007-9327/full/v10/i16/2379.htm
DOI: https://dx.doi.org/10.3748/wjg.v10.i16.2379